In this article, Lana El-Etr analyzes the ethical implications of patenting genetic sequences and discusses the impact on research, patient access to treatments, and the broader implications for public health.
Medications: Navigating the Patent Protection Scheme of Pharmaceutical Companies in the Orange Book
In this article, Ivette Rodríguez Nieves assesses how pharmaceutical companies utilize the FDA’s Orange Book patent listings, resulting in delayed entry from generic competitors. She also examines the FTC’s intervention and analyzes current concerns surrounding the pharmaceutical practices.
The Alice Test’s Frivolous Second Step
In this article, Cassidy Serger discusses how Contour IP Holdings, Inc. v. GoPro interprets the doctrine of patentable subject matter under 35 U.S.C. § 101 of the Patent Act.
If the Inventor is No Longer Human, Then What?: How the USPTO is Addressing AI Assisted Inventions
In this article, Ivette Rodriguez discusses how the USPTO is establishing a framework for patent applicants and examiners in cases where the inventor is listed as a Generative AI system in response to Executive Order 14110.
Sole Rivals: A Dive into Nike and Adidas’ Legal Tussle in IP
In this article, Tyler Walker dives into the long-lived litigation battle between the world’s two largest sport retail companies. He explores the deep history of each company’s respective intellectual property, the arguments behind each lawsuit filed, and the current score in the courtroom.
Space Exploration: Who Owns Commercial Space Projects?
In this article, Magaly Taylor discusses the intellectual property challenges that arise in space exploration, particularly in regard to private entities intending to use their intellectual property for commercial purposes.